69
Participants
Start Date
April 30, 2011
Primary Completion Date
April 30, 2012
Study Completion Date
June 30, 2012
Control
Alli treatment plus placebo (rice flour)
Capolac
Alli treatment plus Capolac supplement (1200 Ca/d from Capolac)
Flax fiber
Alli treatment plus flaxseed fibers (5 g/d of dietary fibers from flaxseed)
Capolac+Flax fiber
Allit treatment plus Capolac (1200 mg Ca/d from Capolac) and Flax fiber (5 g dietary fiber from flaxseed)
Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen, Frederiksberg C
Collaborators (1)
GlaxoSmithKline
INDUSTRY
University of Copenhagen
OTHER